US Patent Issued to REGENERON PHARMACEUTICALS on Oct. 14 for "Human antibodies to artemin and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,784, issued on Oct. 14, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Human antibodies to artemin and methods of use thereof" was invented by Susan D. Croll (New Paltz, N.Y.), Lynn MacDonald (Harrison, N.Y.) and Andrew J. Murphy (Croton-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies and antigen-binding fragments thereof that bind to human artemin. Methods for using anti-artemin antibodies and antigen-binding fragments are also provided."

The patent was filed on Feb. 7, 2024, under Application No. 18/435,815.

*For further information, including images, charts and tables...